Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Type of study
Language
Year range
1.
Braz. j. infect. dis ; 15(1): 28-33, Jan.-Feb. 2011. tab
Article in English | LILACS | ID: lil-576782

ABSTRACT

There is a high incidence of infections caused by betalactamase-producing Gram-negative microorganisms in Brazil. These organisms are of clinical and epidemiological importance, since their mobile genetic elements facilitate cross-infection. The present study was conducted in sentinel rectal swabs from patients admitted to a cardiac surgery hospital in Rio de Janeiro, from January through December 2007, in a consecutive manner. The aim of the study was to characterize the genotype and phenotype of these isolates from colonized patients. Biochemical tests, antimicrobial susceptibility tests, a confirmatory test for the expression of extended spectrum betalactamase (ESBL) production and polymerase chain reaction for the blaTEM, blaSHV, CTX-M1, Toho-1 and AmpC genes were performed at the University Hospital of Universidade do Estado do Rio de Janeiro (UERJ). The most frequently isolated bacteria were Escherichia coli 9/41 (21.95 percent) and Klebsiella pneumoniae 14/41 (34.1 percent). In 24/41 (58 percent), the ESBL genotype was confirmed. The most prevalent genes in samples that expressed ESBL were blaTEM 13/24 (54 percent), AmpC 12/24 (50 percent), blaSHV 6/24 (25 percent), CTX-M1 7/24 (29 percent), and Toho-1 6/24 (25 percent). Of these, 14/24 (58 percent) presented more than one genotype for the tested primers. In nine (37 percent) samples other than E. coli, K. pneumoniae or Proteus spp., the phenotype for ESBL was found and confirmed by PCR. The most sensitive substrate in the approximation test in ESBL positive samples was ceftriaxone (83 percent). Fifty percent of the samples expressed AmpC were associated with other genes. Intermediate susceptibility to ertapenem was found in 2/41 (5 percent).


Subject(s)
Humans , Cross Infection/microbiology , Enterobacteriaceae/enzymology , Intensive Care Units , beta-Lactamases/biosynthesis , Anti-Bacterial Agents/pharmacology , Enterobacteriaceae/drug effects , Enterobacteriaceae/genetics , Enterobacteriaceae/isolation & purification , Genotype , Microbial Sensitivity Tests , Phenotype , Polymerase Chain Reaction , Rectum/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL